Download PDF
Semin Respir Crit Care Med 2009; 30(6): 675-683
DOI: 10.1055/s-0029-1242637
© Thieme Medical Publishers

Pulmonary Rehabilitation and Cardiovascular Disease

Thierry Troosters1 , Hans Van Remoortel1
  • 1Department of Rehabilitation Sciences and Respiratory Division, Katholieke Universiteit, Leuven, Belgium
Further Information

Publication History

Publication Date:
25 November 2009 (online)

    Permissions and Reprints

ABSTRACT

Chronic obstructive pulmonary disease (COPD) and heart disease often coexist. Both diseases share risk factors such as smoking and inactivity. Roughly 15 to 20% of patients referred to pulmonary rehabilitation suffer from some degree of heart failure. Heart failure complicates the presentation of COPD and is often the cause of death in COPD.

Exercise training as part of a comprehensive rehabilitation program is now recognized as a treatment for both COPD and congestive heart failure (CHF). It tackles the skeletal muscle abnormalities commonly seen in these diseases. The rehabilitation program that is offered to patients with COPD and coexisting CHF may need to be adapted in terms of the intensity and the components of self-management and counseling offered. This article discusses these adaptations.

KEYWORDS

Pulmonary rehabilitation - cardiac disease - systemic consequences

REFERENCES

  • 1 Pitta F, Troosters T, Spruit M A, Probst V S, Decramer M, Gosselink R. Characteristics of physical activities in daily life in chronic obstructive pulmonary disease.  Am J Respir Crit Care Med. 2005;  171 972-977
    CrossrefPubMedGoogle Scholar
  • 2 van den Berg-Emons H, Bussmann J, Balk A, Keijzer-Oster D, Stam H. Level of activities associated with mobility during everyday life in patients with chronic congestive heart failure as measured with an “activity monitor”.  Phys Ther. 2001;  81 1502-1511
    PubMedGoogle Scholar
  • 3 Gosker H R, Lencer N HMK, Franssen F M, van der Vusse G J, Wouters E F, Schols A M. Striking similarities in systemic factors contributing to decreased exercise capacity in patients with severe chronic heart failure or COPD.  Chest. 2003;  123 1416-1424
    CrossrefPubMedGoogle Scholar
  • 4 Zvezdin B, Milutinov S, Kojicic M et al.. A postmortem analysis of major causes of early death in patients hospitalized with COPD exacerbation.  Chest. 2009;  136 376-380
    CrossrefPubMedGoogle Scholar
  • 5 Mascarenhas J, Lourenço P, Lopes R, Azevedo A, Bettencourt P. Chronic obstructive pulmonary disease in heart failure: prevalence, therapeutic and prognostic implications.  Am Heart J. 2008;  155 521-525
    CrossrefPubMedGoogle Scholar
  • 6 Decramer M, Rennard S, Troosters T et al.. COPD as a lung disease with systemic consequences: clinical impact, mechanisms, and potential for early intervention.  COPD. 2008;  5 235-256
    CrossrefPubMedGoogle Scholar
  • 7 Topsakal R, Kalay N, Ozdogru I et al.. Effects of chronic obstructive pulmonary disease on coronary atherosclerosis.  Heart Vessels. 2009;  24 164-168
    CrossrefPubMedGoogle Scholar
  • 8 Watz H, Waschki B, Boehme C, Claussen M, Meyer T, Magnussen H. Extrapulmonary effects of chronic obstructive pulmonary disease on physical activity: a cross-sectional study.  Am J Respir Crit Care Med. 2008;  177 743-751
    CrossrefPubMedGoogle Scholar
  • 8a Rabe K F, Hurd S, Anzueto A et al.. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary.  Am J Respir Crit Care Med. 2007;  176 532-555
    CrossrefPubMedGoogle Scholar
  • 9 Rutten F H, Cramer M J, Grobbee D E et al.. Unrecognized heart failure in elderly patients with stable chronic obstructive pulmonary disease.  Eur Heart J. 2005;  26 1887-1894
    CrossrefPubMedGoogle Scholar
  • 10 Witte K K, Clark A L. Why does chronic heart failure cause breathlessness and fatigue?.  Prog Cardiovasc Dis. 2007;  49 366-384
    CrossrefPubMedGoogle Scholar
  • 11 Koechlin C, Couillard A, Simar D et al.. Does oxidative stress alter quadriceps endurance in chronic obstructive pulmonary disease?.  Am J Respir Crit Care Med. 2004;  169 1022-1027
    CrossrefPubMedGoogle Scholar
  • 12 Swallow E B, Gosker H R, Ward K A et al.. A novel technique for nonvolitional assessment of quadriceps muscle endurance in humans.  J Appl Physiol. 2007;  103 739-746
    CrossrefPubMedGoogle Scholar
  • 13 Malaguti C, Nery L E, Dal Corso S et al.. Scaling skeletal muscle function to mass in patients with moderate-to-severe COPD.  Eur J Appl Physiol. 2006;  98 482-488
    CrossrefPubMedGoogle Scholar
  • 14 Allaire J, Maltais F, Doyon J F et al.. Peripheral muscle endurance and the oxidative profile of the quadriceps in patients with COPD.  Thorax. 2004;  59 673-678
    CrossrefPubMedGoogle Scholar
  • 15 Coronell C, Orozco-Levi M, Méndez R, Ramírez-Sarmiento A, Gáldiz J B, Gea J. Relevance of assessing quadriceps endurance in patients with COPD.  Eur Respir J. 2004;  24 129-136
    CrossrefPubMedGoogle Scholar
  • 16 Couillard A, Maltais F, Saey D et al.. Exercise-induced quadriceps oxidative stress and peripheral muscle dysfunction in patients with chronic obstructive pulmonary disease.  Am J Respir Crit Care Med. 2003;  167 1664-1669
    CrossrefPubMedGoogle Scholar
  • 17 Serres I, Gautier V, Varray A, Préfaut C. Impaired skeletal muscle endurance related to physical inactivity and altered lung function in COPD patients.  Chest. 1998;  113 900-905
    CrossrefPubMedGoogle Scholar
  • 18 Wilson J R, Martin J L, Schwartz D, Ferraro N. Exercise intolerance in patients with chronic heart failure: role of impaired nutritive flow to skeletal muscle.  Circulation. 1984;  69 1079-1087
    PubMedGoogle Scholar
  • 19 Saey D, Debigare R, LeBlanc P et al.. Contractile leg fatigue after cycle exercise: a factor limiting exercise in patients with chronic obstructive pulmonary disease.  Am J Respir Crit Care Med. 2003;  168 425-430
    CrossrefPubMedGoogle Scholar
  • 20 Decramer M, Gosselink R, Troosters T, Verschueren M, Evers G. Muscle weakness is related to utilization of health care resources in COPD patients.  Eur Respir J. 1997;  10 417-423
    CrossrefPubMedGoogle Scholar
  • 21 Swallow E B, Reyes D, Hopkinson N S et al.. Quadriceps strength predicts mortality in patients with moderate to severe chronic obstructive pulmonary disease.  Thorax. 2007;  62 115-120
    CrossrefPubMedGoogle Scholar
  • 22 Izawa K P, Watanabe S, Osada N et al.. Handgrip strength as a predictor of prognosis in Japanese patients with congestive heart failure.  Eur J Cardiovasc Prev Rehabil. 2009;  16 21-27
    CrossrefPubMedGoogle Scholar
  • 23 Sala E, Roca J, Marrades R M et al.. Effects of endurance training on skeletal muscle bioenergetics in chronic obstructive pulmonary disease.  Am J Respir Crit Care Med. 1999;  159 1726-1734
    CrossrefPubMedGoogle Scholar
  • 24 Wagner P D. Skeletal muscles in chronic obstructive pulmonary disease: deconditioning, or myopathy?.  Respirology. 2006;  11 681-686
    CrossrefPubMedGoogle Scholar
  • 25 Bernard S, LeBlanc P, Whittom F et al.. Peripheral muscle weakness in patients with chronic obstructive pulmonary disease.  Am J Respir Crit Care Med. 1998;  158 629-634
    CrossrefPubMedGoogle Scholar
  • 26 Harrington D, Anker S D, Chua T P et al.. Skeletal muscle function and its relation to exercise tolerance in chronic heart failure.  J Am Coll Cardiol. 1997;  30 1758-1764
    CrossrefPubMedGoogle Scholar
  • 27 Decramer M, Lacquet L M, Fagard R, Rogiers P. Corticosteroids contribute to muscle weakness in chronic airflow obstruction.  Am J Respir Crit Care Med. 1994;  150 11-16
    CrossrefPubMedGoogle Scholar
  • 28 Spruit M A, Gosselink R, Troosters T et al.. Muscle force during an acute exacerbation in hospitalised patients with COPD and its relationship with CXCL8 and IGF-I.  Thorax. 2003;  58 752-756
    CrossrefPubMedGoogle Scholar
  • 29 Pitta F, Troosters T, Probst V S, Spruit M A, Decramer M, Gosselink R. Physical activity and hospitalization for exacerbation of COPD.  Chest. 2006;  129 536-544
    CrossrefPubMedGoogle Scholar
  • 30 Gosker H R, Wouters E F, van der Vusse G J, Schols A M. Skeletal muscle dysfunction in chronic obstructive pulmonary disease and chronic heart failure: underlying mechanisms and therapy perspectives.  Am J Clin Nutr. 2000;  71 1033-1047
    PubMedGoogle Scholar
  • 31 Stassijns G, Lysens R, Decramer M. Peripheral and respiratory muscles in chronic heart failure.  Eur Respir J. 1996;  9 2161-2167
    CrossrefPubMedGoogle Scholar
  • 32 Filippatos G S, Tsilias K, Venetsanou K et al.. Leptin serum levels in cachectic heart failure patients: relationship with tumor necrosis factor-alpha system.  Int J Cardiol. 2000;  76 117-122
    CrossrefPubMedGoogle Scholar
  • 33 Creutzberg E C, Schols A M, Weling-Scheepers C A, Buurman W A, Wouters E F. Characterization of nonresponse to high caloric oral nutritional therapy in depleted patients with chronic obstructive pulmonary disease.  Am J Respir Crit Care Med. 2000;  161(3 Pt 1) 745-752
    PubMedGoogle Scholar
  • 34 Agustí A G, Sauleda J, Miralles C et al.. Skeletal muscle apoptosis and weight loss in chronic obstructive pulmonary disease.  Am J Respir Crit Care Med. 2002;  166 485-489
    CrossrefPubMedGoogle Scholar
  • 35 Gosker H R, Kubat B, Schaart G, van der Vusse G J, Wouters E F, Schols A M. Myopathological features in skeletal muscle of patients with chronic obstructive pulmonary disease.  Eur Respir J. 2003;  22 280-285
    CrossrefPubMedGoogle Scholar
  • 36 Adams V, Jiang H, Yu J et al.. Apoptosis in skeletal myocytes of patients with chronic heart failure is associated with exercise intolerance.  J Am Coll Cardiol. 1999;  33 959-965
    CrossrefPubMedGoogle Scholar
  • 37 Gan W Q, Man S F, Senthilselvan A, Sin D D. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis.  Thorax. 2004;  59 574-580
    CrossrefPubMedGoogle Scholar
  • 38 Barreiro E, Schols A M, Polkey M I ENIGMA in COPD project et al. Cytokine profile in quadriceps muscles of patients with severe COPD.  Thorax. 2008;  63 100-107
    PubMedGoogle Scholar
  • 39 Vogiatzis I, Stratakos G, Simoes D C et al.. Effects of rehabilitative exercise on peripheral muscle TNFalpha, IL-6, IGF-I and MyoD expression in patients with COPD.  Thorax. 2007;  62 950-956
    CrossrefPubMedGoogle Scholar
  • 40 Rabinovich R A, Figueras M, Ardite E et al.. Increased tumour necrosis factor-alpha plasma levels during moderate-intensity exercise in COPD patients.  Eur Respir J. 2003;  21 789-794
    CrossrefPubMedGoogle Scholar
  • 41 Crul T, Spruit M A, Gayan-Ramirez G et al.. Markers of inflammation and disuse in vastus lateralis of chronic obstructive pulmonary disease patients.  Eur J Clin Invest. 2007;  37 897-904
    CrossrefPubMedGoogle Scholar
  • 42 Ventura-Clapier R, De Sousa E, Veksler V. Metabolic myopathy in heart failure.  News Physiol Sci. 2002;  17 191-196
    PubMedGoogle Scholar
  • 43 Linke A, Adams V, Schulze P C et al.. Antioxidative effects of exercise training in patients with chronic heart failure: increase in radical scavenger enzyme activity in skeletal muscle.  Circulation. 2005;  111 1763-1770
    CrossrefPubMedGoogle Scholar
  • 44 Van Vliet M, Spruit M A, Verleden G et al.. Hypogonadism, quadriceps weakness, and exercise intolerance in chronic obstructive pulmonary disease.  Am J Respir Crit Care Med. 2005;  172 1105-1111
    CrossrefPubMedGoogle Scholar
  • 45 Kontoleon P E, Anastasiou-Nana M I, Papapetrou P D et al.. Hormonal profile in patients with congestive heart failure.  Int J Cardiol. 2003;  87 179-183
    CrossrefPubMedGoogle Scholar
  • 46 Jankowska E A, Biel B, Majda J et al.. Anabolic deficiency in men with chronic heart failure: prevalence and detrimental impact on survival.  Circulation. 2006;  114 1829-1837
    CrossrefPubMedGoogle Scholar
  • 47 Casaburi R, Bhasin S, Cosentino L et al.. Effects of testosterone and resistance training in men with chronic obstructive pulmonary disease.  Am J Respir Crit Care Med. 2004;  170 870-878
    CrossrefPubMedGoogle Scholar
  • 48 Janssens W, Lehouck A, Carremans C, Bouillon R, Mathieu C, Decramer M. Vitamin D beyond bones in chronic obstructive pulmonary disease: time to act.  Am J Respir Crit Care Med. 2009;  179 630-636
    CrossrefPubMedGoogle Scholar
  • 49 Hopkinson N S, Li K W, Kehoe A et al.. Vitamin D receptor genotypes influence quadriceps strength in chronic obstructive pulmonary disease.  Am J Clin Nutr. 2008;  87 385-390
    PubMedGoogle Scholar
  • 50 Murakami S, Otsuki T, Maeda M et al.. Effects of vitamin D receptor gene polymorphisms on low-resistance training using exercise machines: the ‘Power Rehabilitation’ program.  Int J Mol Med. 2009;  23 81-88
    PubMedGoogle Scholar
  • 51 Rees K, Taylor R S, Singh S, Coats A J, Ebrahim S. Exercise based rehabilitation for heart failure.  Cochrane Database Syst Rev. 2004;  (3) CD003331
    PubMedGoogle Scholar
  • 52 Lacasse Y, Goldstein R, Lasserson T J, Martin S. Pulmonary rehabilitation for chronic obstructive pulmonary disease.  Cochrane Database Syst Rev. 2006;  (4) CD003793
    PubMedGoogle Scholar
  • 53 Troosters T, Gosselink R, Decramer M. Short- and long-term effects of outpatient rehabilitation in patients with chronic obstructive pulmonary disease: a randomized trial.  Am J Med. 2000;  109 207-212
    CrossrefPubMedGoogle Scholar
  • 54 O’Donnell D E, McGuire M, Samis L, Webb K A. General exercise training improves ventilatory and peripheral muscle strength and endurance in chronic airflow limitation.  Am J Respir Crit Care Med. 1998;  157(5 Pt 1) 1489-1497
    PubMedGoogle Scholar
  • 55 Mador M J, Bozkanat E, Aggarwal A, Shaffer M, Kufel T J. Endurance and strength training in patients with COPD.  Chest. 2004;  125 2036-2045
    CrossrefPubMedGoogle Scholar
  • 56 Ortega F, Toral J, Cejudo P et al.. Comparison of effects of strength and endurance training in patients with chronic obstructive pulmonary disease.  Am J Respir Crit Care Med. 2002;  166 669-674
    CrossrefPubMedGoogle Scholar
  • 57 Bernard S, Whittom F, Leblanc P et al.. Aerobic and strength training in patients with chronic obstructive pulmonary disease.  Am J Respir Crit Care Med. 1999;  159 896-901
    PubMedGoogle Scholar
  • 58 Kobayashi N, Tsuruya Y, Iwasawa T et al.. Exercise training in patients with chronic heart failure improves endothelial function predominantly in the trained extremities.  Circ J. 2003;  67 505-510
    CrossrefPubMedGoogle Scholar
  • 59 Hambrecht R, Fiehn E, Weigl C et al.. Regular physical exercise corrects endothelial dysfunction and improves exercise capacity in patients with chronic heart failure.  Circulation. 1998;  98 2709-2715
    CrossrefPubMedGoogle Scholar
  • 60 Conraads V M, Beckers P, Bosmans J et al.. Combined endurance/resistance training reduces plasma TNF-alpha receptor levels in patients with chronic heart failure and coronary artery disease.  Eur Heart J. 2002;  23 1854-1860
    CrossrefPubMedGoogle Scholar
  • 61 Rabinovich R A, Ardite E, Troosters T et al.. Reduced muscle redox capacity after endurance training in patients with chronic obstructive pulmonary disease.  Am J Respir Crit Care Med. 2001;  164 1114-1118
    PubMedGoogle Scholar
  • 62 Piepoli M F, Davos C, Francis D P, Coats A J. ExTraMATCH Collaborative . Exercise training meta-analysis of trials in patients with chronic heart failure (ExTraMATCH).  BMJ. 2004;  328 189
    CrossrefPubMedGoogle Scholar
  • 63 O’Connor C M, Whellan D J, Lee K L HF-ACTION Investigators et al. Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial.  JAMA. 2009;  301 1439-1450
    CrossrefPubMedGoogle Scholar
  • 64 Puhan M, Scharplatz M, Troosters T, Walters E H, Steurer J. Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease.  Cochrane Database Syst Rev. 2009;  (1) CD005305
    PubMedGoogle Scholar
  • 65 Troosters T, Casaburi R, Gosselink R, Decramer M. Pulmonary rehabilitation in chronic obstructive pulmonary disease.  Am J Respir Crit Care Med. 2005;  172 19-38
    CrossrefPubMedGoogle Scholar
  • 66 Hunt S A, Abraham W T, Chin M H American College of Cardiology Foundation et al. 2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines developed in collaboration with the International Society for Heart and Lung Transplantation.  J Am Coll Cardiol. 2009;  53 e1-e90
    CrossrefPubMedGoogle Scholar
  • 67 Nici L, Donner C, Wouters E ATS/ERS Pulmonary Rehabilitation Writing Committee et al. American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation.  Am J Respir Crit Care Med. 2006;  173 1390-1413
    CrossrefPubMedGoogle Scholar
  • 68 Vogiatzis I, Nanas S, Roussos C. Interval training as an alternative modality to continuous exercise in patients with COPD.  Eur Respir J. 2002;  20 12-19
    CrossrefPubMedGoogle Scholar
  • 69 Vogiatzis I, Terzis G, Nanas S et al.. Skeletal muscle adaptations to interval training in patients with advanced COPD.  Chest. 2005;  128 3838-3845
    CrossrefPubMedGoogle Scholar
  • 70 Puhan M A, Büsching G, Schünemann H J, VanOort E, Zaugg C, Frey M. Interval versus continuous high-intensity exercise in chronic obstructive pulmonary disease: a randomized trial.  Ann Intern Med. 2006;  145 816-825
    CrossrefPubMedGoogle Scholar
  • 71 Wisløff U, Støylen A, Loennechen J P et al.. Superior cardiovascular effect of aerobic interval training versus moderate continuous training in heart failure patients: a randomized study.  Circulation. 2007;  115 3086-3094
    CrossrefPubMedGoogle Scholar
  • 72 Meyer K, Samek L, Schwaibold M et al.. Interval training in patients with severe chronic heart failure: analysis and recommendations for exercise procedures.  Med Sci Sports Exerc. 1997;  29 306-312
    PubMedGoogle Scholar
  • 73 Dolmage T E, Goldstein R S. Effects of one-legged exercise training of patients with COPD.  Chest. 2008;  133 370-376
    CrossrefPubMedGoogle Scholar
  • 74 Emtner M, Porszasz J, Burns M, Somfay A, Casaburi R. Benefits of supplemental oxygen in exercise training in nonhypoxemic chronic obstructive pulmonary disease patients.  Am J Respir Crit Care Med. 2003;  168 1034-1042
    CrossrefPubMedGoogle Scholar
  • 75 Hawkins P, Johnson L C, Nikoletou D et al.. Proportional assist ventilation as an aid to exercise training in severe chronic obstructive pulmonary disease.  Thorax. 2002;  57 853-859
    CrossrefPubMedGoogle Scholar
  • 76 Casaburi R, Kukafka D, Cooper C B, Witek Jr T J, Kesten S. Improvement in exercise tolerance with the combination of tiotropium and pulmonary rehabilitation in patients with COPD.  Chest. 2005;  127 809-817
    CrossrefPubMedGoogle Scholar
  • 77 Eves N D, Sandmeyer L C, Wong E Y et al.. Helium-hyperoxia: a novel intervention to improve the benefits of pulmonary rehabilitation for patients with COPD.  Chest. 2009;  135 609-618
    CrossrefPubMedGoogle Scholar
  • 78 Probst V S, Troosters T, Pitta F, Decramer M, Gosselink R. Cardiopulmonary stress during exercise training in patients with COPD.  Eur Respir J. 2006;  27 1110-1118
    CrossrefPubMedGoogle Scholar
  • 79 Spruit M A, Eterman R M, Hellwig V, Janssen P, Wouters E, Uszko-Lencer N. Effects of moderate-to-high intensity resistance training in patients with chronic heart failure.  Heart. 2009;  95 1399-1408
    CrossrefPubMedGoogle Scholar
  • 80 Braith R W, Beck D T. Resistance exercise: training adaptations and developing a safe exercise prescription.  Heart Fail Rev. 2008;  13 69-79
    CrossrefPubMedGoogle Scholar
  • 81 Troosters T. Endurance versus strength training in chronic obstructive pulmonary disease, II: Resistance training.  Chron Respir Dis. 2004;  1 40-41
    PubMedGoogle Scholar
  • 82 Levinger I, Bronks R, Cody D V, Linton I, Davie A. The effect of resistance training on left ventricular function and structure of patients with chronic heart failure.  Int J Cardiol. 2005;  105 159-163
    CrossrefPubMedGoogle Scholar
  • 83 Beckers P J, Denollet J, Possemiers N M, Wuyts F L, Vrints C J, Conraads V M. Combined endurance-resistance training vs. endurance training in patients with chronic heart failure: a prospective randomized study.  Eur Heart J. 2008;  29 1858-1866
    CrossrefPubMedGoogle Scholar
  • 84 Sillen M J, Speksnijder C M, Eterman R M et al.. Effects of neuromuscular electrical stimulation of muscles of ambulation in patients with chronic heart failure or COPD: a systematic review of the English-language literature.  Chest. 2009;  136 44-61
    CrossrefPubMedGoogle Scholar
  • 85 Neder J A, Sword D, Ward S A, Mackay E, Cochrane L M, Clark C J. Home based neuromuscular electrical stimulation as a new rehabilitative strategy for severely disabled patients with chronic obstructive pulmonary disease (COPD).  Thorax. 2002;  57 333-337
    CrossrefPubMedGoogle Scholar
  • 86 Vivodtzev I, Pépin J L, Vottero G et al.. Improvement in quadriceps strength and dyspnea in daily tasks after 1 month of electrical stimulation in severely deconditioned and malnourished COPD.  Chest. 2006;  129 1540-1548
    CrossrefPubMedGoogle Scholar
  • 87 Myers J. Principles of exercise prescription for patients with chronic heart failure.  Heart Fail Rev. 2008;  13 61-68
    CrossrefPubMedGoogle Scholar

Thierry TroostersPh.D. 

Respiratory Division, Katholieke Universiteit

O&N I Herestraat 49 bus 706, BE-3000 Leuven, Belgium

Email: Thierry.troosters@med.kuleuven.be

      >